Browsing: STX
Specialist pharmaceutical maker Shield Therapeutics (STX) delivered investors more good news with the potential approval of ACCRUFeR in China. The…
SHIELD THERAPEUTICS (STX) – Pharmaceuticals Price: 11.65p +3.6%P/E: n/aMarket Cap: £123mYield: n/a Positive news from the late-stage AIM-listed drug company…